Search Results "#Neuropsychiatry"

Blogs

arrow_forward View More Results
Pseudobulbar Treatment Market: How Is Dextromethorphan-Quinidine Fixed-Dose Therapy Becoming the Fastest-Growing Pharmacological Standard?
Posted by Surbhi on July 24 2026 at 06:05 PM   public
Dextromethorphan-quinidine fixed-dose combination (Nuedexta, Avanir/Otsuka) — the first FDA-approved therapy specifically indicated for pseudobulbar affect (PBA) in amyotrophic lateral sclerosis ...
arrow_forward